Isolated Alkaline Phosphatase Elevation in Severe Osteoporosis Treatment: Implications of Teriparatide

Authors

Nazmul Hasan, UCIMC: UCI Medical Center, USAFollow
Emilie Chow, UCIMC: UCI Medical Center, USA
Daniel Yang, UCIMC: UCI Medical Center, USA
Priyanka Iyer, UCIMC: UCI Medical Center, USA
Andrew Reikes, UCIMC: UCI Medical Center, USA

Abstract

In severe osteoporosis, anabolic agents such as teriparatide (Forteo) are more commonly used. As a PTH analog, Teripararide has a limited side effect profile with potential for mild hypercalcemia and dyspepsia. In this report we highlight another less common side effect, asymptomatic elevation in alkaline phosphatase.

Recommended Citation

Hasan, Nazmul; Chow, Emilie; Yang, Daniel; Iyer, Priyanka; and Reikes, Andrew (2024) "Isolated Alkaline Phosphatase Elevation in Severe Osteoporosis Treatment: Implications of Teriparatide," Journal of Community Hospital Internal Medicine Perspectives: Vol. 14: Iss. 6, Article 16.
DOI: 10.55729/2000-9666.1407
Available at: https://scholarlycommons.gbmc.org/jchimp/vol14/iss6/16